Trending...
- Lemon Buddy - #1 Ranked California Lemon Law Firm
- California: Governor Newsom signs first-of-its-kind executive order to prepare workers and businesses for potential AI disruption
- Superconductors: The Sovereign Standard
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY) on behalf of investors concerning the Company's possible violations of federal securities laws.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
On March 28, 2023, Scorpion Capital published a report alleging, among other things, that Harmony's narcolepsy drug, Wakix, has "alarming toxicity," "no efficacy," is based on "sham patents," and "scam clinical trials," and has been "pushed via false advertising and a vast off-label and physician kickback scheme."
On this news, Harmony's share price fell $10.70 per share, or 25.8%, to close at $30.80 per share on March 28, 2023, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Harmony securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
More on The Californer
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- Jetperch Introduces Joulescope JS320 Precision Energy Analyzer for Low-Power Embedded System Development
- California: Governor Newsom proclaims Small Business Month
- AI-Powered Trading Bots Are Transforming Forex, Gold, and Digital Markets as DefiHash Expands Intelligent Quantitative Infrastructure
- Early Bird Registration Open for FLYING HY, the Top Hydrogen and Battery Electric Aviation Event
- Century Fasteners Corp. Hires Tony Marano as Director of Human Resources
On March 28, 2023, Scorpion Capital published a report alleging, among other things, that Harmony's narcolepsy drug, Wakix, has "alarming toxicity," "no efficacy," is based on "sham patents," and "scam clinical trials," and has been "pushed via false advertising and a vast off-label and physician kickback scheme."
On this news, Harmony's share price fell $10.70 per share, or 25.8%, to close at $30.80 per share on March 28, 2023, thereby injuring investors.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you purchased Harmony securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
More on The Californer
- Indemnify AI Submits Comment Letter to SEC Urging Dollar-Based AI Risk Disclosure
- Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
- New Wisconsin Report Shows Most Plane Crashes Happen Outside Major Hubs
- 16 months after LA fires, only dozens of homes rebuilt. StackHaus pledges $750K for 500 survivors
- Bracelet Stack Styling: How To Create The Effortless Luxury Look
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com
Filed Under: Business
0 Comments
Latest on The Californer
- Harvest Properties and Lone Star Funds Form JV to Recapitalize San Francisco Office Tower
- This Is Your Captain Speaking documentary to premiere at Laemmle in Santa Monica
- Buzzblender Announces Launch of Simple Hotel Mode for Android and Upcoming Video Wall Support for Samsung Professional Displays
- How Strategic WooCommerce Development and Digital Marketing Helped a Fashion Ecommerce Business Increase Revenue by 3X
- VIV Welcomes Residents to St. Petersburg's EDGE District
- Evocative Joins the Independent Data Centre Network (IDCN) as Primary USA Operator
- California Lemon Law Process Explained By Los Angeles Lemon Law Attorney
- Learn Window Tinting in Los Angeles with the Tint Academy – June 20th & 21st
- Award-Winning"The Prayer: Rise with Jesus" Becomes #1 Bestseller in the U.S., Italy, and Brazil
- Medical Experts Highlight the Importance of Second Opinions in Death Investigations
- 8 Figure Trader Christopher Hunt Is Redefining Modern Trading Education
- California: Governor Newsom secures Presidential Emergency Declaration approval for Orange County hazmat response
- Joseph Nybyk aka Neibich of Gilbert, Arizona
- California: Governor Newsom proclaims Memorial Day
- Absolute Exhibits Mourns the Passing of Founder Jan Koren
- Omnitronics Unveils 100% Software omniGateDMR and omniGateP25 RoIP Gateways
- California mobilizes 785+ emergency personnel in Orange County hazmat response
- KRE PRIME Launches Adaptive Convertible Jumpsuit
- California: Governor Newsom submits request to President Trump for emergency declaration to support response efforts in Orange County
- Vindicara Launches the First Open-Source Runtime Security Platform for AI Agents